Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Worg Pharmaceuticals
company
About
Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergy and other diseases.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥400M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥400M
Worg Pharmaceuticals has raised a total of
¥400M
in funding over 2 rounds. Their latest funding was raised on
Sep 14, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 14, 2022 | Series B | ¥400M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Worg Pharmaceuticals is funded by 1 investors.
Longqian Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
